Cyclodextrin-polyethylenimine conjugates for targeted in vitro gene delivery

Area of Science:

• Biotechnology
• Polymer Chemistry
• Gene Therapy

Background:

• Cell-specific targeting is crucial for effective human gene therapies.
• Nonviral polymer vectors offer targetability via ligand conjugation, unlike less adaptable viral vectors.
• Cyclodextrin incorporation into polymers provides versatile attachment sites for targeting ligands.

Purpose of the Study:

• To develop and evaluate a novel gene delivery polymer, cyclodextrin-polyethylenimine (CD-PEI), for enhanced cell-specific targeting.
• To assess the toxicity and gene expression efficiency of CD-PEI compared to unmodified polyethylenimine (PEI).
• To investigate the synergistic effect of hydrophobic modification and ligand attachment on gene delivery enhancement.

Main Methods:

• Polyethylenimine (PEI) was modified with beta-cyclodextrin to create CD-PEI.
• Human insulin was derivatized with a hydrophobic palmitate group (pal-HI) for anchoring.
• HEK293 cells were used to evaluate the non-toxicity and gene delivery efficiency of CD-PEI/DNA polyplexes, with and without pal-HI.

Main Results:

• CD-PEI demonstrated minimal toxicity to HEK293 cells at optimal gene delivery concentrations.
• CD-PEI mediated nearly 4-fold higher gene expression compared to unmodified PEI.
• The addition of pal-HI to CD-PEI/DNA polyplexes enhanced gene expression by over an order of magnitude compared to unmodified PEI.

Conclusions:

• CD-PEI is a non-toxic and effective nonviral gene delivery vector.
• The cyclodextrin moiety offers a versatile platform for attaching various cell-specific targeting ligands.
• CD-PEI represents a promising material for developing targeted gene therapies with significantly improved efficacy.